GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes
Clinical trial NCT00229710 · TERMINATED
Trial details
- NCT number
- NCT00229710
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Primary completion
- 2006-12-01
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.